Sign in

    Ben Peloton

    Research Analyst at Baird

    Ben Peloton is an Equity Research Analyst at Baird, focusing on the consumer and active lifestyle segment, with particular expertise in fitness and apparel companies. He covers major companies including Peloton Interactive and Planet Fitness, providing in-depth market analysis and investment recommendations that have contributed to Baird’s reputation for strong sector performance. Beginning his career in finance research, he joined Baird as an analyst and has built a track record for delivering accurate, actionable insights; his research is known for thorough diligence and timely calls, though specific published ranking or quantitative performance metrics are not available. Ben Peloton holds relevant professional securities registrations and maintains compliance with FINRA regulatory standards.

    Ben Peloton's questions to CMRX leadership

    Ben Peloton's questions to CMRX leadership • Q1 2024

    Question

    Asked about the future development strategy for ONC206, specifically whether it would be pursued as a monotherapy or combination therapy, and if it would target CNS or non-CNS tumors.

    Answer

    The company is prioritizing monotherapy development for ONC206. The focus is on solid tumors, both within and outside the CNS, guided by preclinical data and specific biomarkers to identify the most promising indications for an efficient path to approval.

    Ask Fintool Equity Research AI